Press Release

Feb, 14 2024

Revolutionizing Research: Advancements and Applications of Automated Cell Cultures for Precision Biomedical Innovations

Automated cell cultures refer to the use of advanced technologies to streamline the process of growing and maintaining cells in a laboratory setting. These systems employ robotics, sensors, and software to automate tasks such as media exchange, monitoring cell health, and controlling environmental conditions. This approach enhances reproducibility, reduces manual labor, and provides a controlled environment for cells to thrive, making it an invaluable tool in various fields such as drug discovery, regenerative medicine, and biotechnology.

Access Full Report @

Data Bridge Market Research analyses that the North America Automated Cell Cultures Market is growing with a CAGR of 9.1% in the forecast period of 2022 to 2029 and is expected to reach EURO 7,797.02 million by 2029, which was EURO 3,884.46 million in 2021. The surge in demand for cell-based therapies and the emergence of cell-based vaccines are significant drivers propelling the growth of the automated cell culture market in North America.

Key Findings of the Study

North America Automated Cell Cultures Market

Regenerative medicine is expected to drive the market's growth rate

The growing field of regenerative medicine sees a surge in interest, particularly in applications such as tissue engineering and stem cell research. Automated cell cultures assume a pivotal role in this landscape, facilitating precise control over cell growth, differentiation, and manipulation. These technologies streamline processes, ensuring the reproducibility of cell-based therapies. Their integration empowers researchers in advancing regenerative medicine, fostering breakthroughs in tissue repair, organ transplantation, and personalized treatments, marking a transformative era in healthcare innovation.

Report Scope and Market Segmentation

Report Metric


Forecast Period

2022 to 2029

Base Year


Historic Years

2020 (Customizable to 2014-2019)

Quantitative Units

Revenue in EURO Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Consumables, Instruments), Type (Infinite Cell Line Cultures, Finite Cell Line Cultures), Application (Drug Development, Stem Cell Research, Regenerative Medicine, Cancer Research, Vaccines, Others), End User (Biotech Companies, Research Organizations, Academic Research Institutes, Other)

Countries Covered

U.S., Canada and Mexico in North America

Market Players Covered

Lonza (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), BD (Becton, Dickinson and Company) (U.S.), Eppendorf AG (Germany) among others            

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The North America automated cell cultures market is segmented into product, type, application, and end user.

  • On the basis of product, the North America automated cell cultures market is segmented into consumables and instruments
  • On the basis of type, the North America automated cell cultures market is segmented into infinite cell line cultures and finite cell line cultures
  • On the basis of application, the North America automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccine, and other
  • On the basis of end user, the North America automated cell cultures market is segmented into biotech companies, research organizations, academic research institutes, and other

Major Players

Data Bridge Market Research recognizes the following companies as the major North America automated cell cultures market players in North America automated cell cultures market are Lonza (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), BD (Becton, Dickinson and Company) (U.S.), Eppendorf AG (Germany)

North America Automated Cell Cultures Market

Market Developments

  • In August 2021, Advanced Instruments, a prominent manufacturer of bioprocessing analytical instruments, finalized an acquisition agreement with Solentim, a distinguished leader in North America for solutions in isolating and characterizing single-cell clones. This strategic move enhances both companies' roles in bioprocess workflows, particularly in cell line development applications. The alliance strengthens their capabilities to support the evolving demands of advanced therapies within the biopharmaceutical industry
  • In July 2021, BD launched, a revamped digital marketplace catering to flow cytometry. This platform elevates the online purchasing journey for both flow cytometry users and procurement teams, offering an enhanced experience. The updated website reflects BD's commitment to providing streamlined access and improved functionalities for the flow cytometry community, fostering efficiency and convenience in procurement processes
  • In May 2021, Lonza launched the latest iteration of its Nucleofector Platform, featuring intuitive software for enhanced flexibility and reliable performance. This innovation significantly expanded Lonza's product portfolio, contributing to the growth of the automated cell cultures market. The advanced platform streamlines cell manipulation processes, fostering increased efficiency and precision in applications such as gene editing, thereby catalyzing the broader adoption of automated cell culture technologies
  • In April 2021, Thermo Fisher Scientific Inc finalized a deal to acquire PPD, Inc. for USD 17.4 Billion, at USD 47.50/share. This strategic move enhances Thermo Fisher's capabilities and resources. The expanded expertise is expected to strengthen advancements in automated cell cultures, fostering growth in this market segment. The acquisition positions Thermo Fisher to contribute significantly to evolving research, particularly in fields such as regenerative medicine and biopharmaceuticals

For more detailed information about the North America automated cell cultures market report, click here –

Client Testimonials